Live Breaking News & Updates on Three Targeted Therapies

Stay updated with breaking news from Three targeted therapies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Global Companion Diagnostic Markets Report 2021-2025: Level of Care, Immuno-oncology, Liability & Aging Population Driving Growth


Will Personalized Companion Diagnostics become the norm for diagnostics?
Companion Diagnostics are poised to revolutionize the diagnostics industry. The market is finally moving out of the lab and into the clinic. Oncology, especially immune-oncology is leading the way. And the FDA is holding the door open for this diagnostic technology of the future. But COVID-19 is impacting healthcare treatment everywhere and lowering demand for specialized cancer testing. Find out the latest outlook for this important market.
Learn all about how diagnostic players are jockeying for position with their pharmaceutical counterparts and creating new and significant business opportunities. And some players are already taking the lead. It is a dynamic market situation with enormous opportunity. Diagnostic companies are trying to back the right horse. The science is racing forward. And the cost of molecular diagnostics continues to fall. ....

United States , Miltenyi Biotec , Qiagen Gmbh , Sysmex Inostics , Bristol Myers Squibb , Cdx Therascreen , Siemens Healthineers , Laura Wood , Academic Research Lab , Castle Biosciences Inc , Testing Lab , Public National , Central Lab , Technology Development , Singlera Genomics Inc , Endpoint Health , Enzo Life Sciences Inc , Office Hours Call , Biodesix Inc , Datar Cancer Genetics , Fluidigm Corp , Accuragen Inc , Guardant Health To Develop Cdx For Janssen , Business Development Staff , Genefirst Ltd , Bioneer Corporation ,